Stay updated on AK002 for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the AK002 for Eosinophilic Gastritis Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check58 days agoChange DetectedThe page has undergone significant content removal regarding a Phase 3 study of lirentelimab (AK002) for Eosinophilic Gastritis, including detailed inclusion and exclusion criteria, while a new revision number has been added.SummaryDifference27%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to AK002 for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.